Our CEO, Dr David Ribeiro, will be attending the DxPx Conference, taking place face-to-face in Dusseldorf and in a virtual format, November 12th – 20th 2021.
ProAxsis are actively seeking commercial partners for our portfolio of respiratory diagnostics in key territories. These include:
- Laboratory-based assays for active protease biomarkers associated with chronic respiratory diseases such as cystic fibrosis, bronchiectasis and COPD.
- NEATstik, a qualitative point-of-care test for active neutrophil elastase.
- Our Covid-19 serology test, developed in partnership with AstraZeneca.
If your company has access to pre-existing networks of key respiratory groups, and you’d be interested in exploring any of these exciting opportunities then please contact David to request a meeting via email@example.com or the DxPx conference partnering system.